Navigation Links
CuraGen Presents Update on Clinical Development Program for,Belinostat

looking statements, whether as a result of new information, future events or otherwise.

    CRGN-P


    Contact:

    Glenn Schulman, PharmD

    Director of Investor Relations

    

    (888) 436-6642
gschulman@curagen.com

CONTACT: Glenn Schulman, PharmD, Director of Investor Relations of CuraGenCorporation, 888-436-6642, gschulman@curagen.com

Web site: http://www.curagen.com/

Ticker Symbol: (NASDAQ-NMS:CRGN)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
2. CuraGen Announces New Preclinical Results with Belinostat and Velafermin to be Presented at AACR Annual Meeting
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting

Post Your Comments:
(Date:11/19/2009)...-- In response to an ever-increasing number of web...peration Pangea II, involving 24 countries, was co...ation,s International Medical Products Anti-Counte...rs of buying medicines online. ,, The week long... and the seizure of thousands of potentially harmf...
(Date:11/19/2009)...- Riverain Medical announced today that the compan... imaging distributor Christie Group to offer SoftV...CAD. The exclusive agreement will bring Dayton, Oh...an market through Christie Group,s established and...Chest Imaging increases the clarity of digital che...
(Date:11/19/2009)...Week of Action ,, SILVER SPRING, Md., Nov. 19 ...Administration today completed a coordinated, week...al Internet Week of Action (IIWA), intended to cur..., (Logo: http://www.newscom.com/cgi-bin/prnh/2009...Office of Criminal Investigations (OCI), in conjun...
Breaking Medicine Technology:International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Maternal child health focus of African Science Academies meeting in Ghana Nov 9 11 58053 1McDonalization of frogs 10037 1McDonalization of frogs 10037 2McDonalization of frogs 10037 3McDonalization of frogs 10037 4Independence Blue Cross Wins Disease Management Association of Americas Quality Award for Greatest Impact on Satisfaction 58048 1Independence Blue Cross Wins Disease Management Association of Americas Quality Award for Greatest Impact on Satisfaction 58048 2Independence Blue Cross Wins Disease Management Association of Americas Quality Award for Greatest Impact on Satisfaction 58048 3Independence Blue Cross Wins Disease Management Association of Americas Quality Award for Greatest Impact on Satisfaction 58048 4
...GO, Nov. 6 Vical Incorporated (Nasdaq:,VICL) toda... (NMRC) plans,to conduct preclinical and Phase 1 e...the company,s Vaxfectin(R) adjuvant and delivered ...ystem (Bioject Medical,Technologies Inc.) (OTC Bul...l will manufacture the vaccine and the adjuvant un...
...arm Submits Response to the FDA, LAUSANNE, Switze...a global biopharmaceutical development specialist ...ticularly oncology, announced,today that Debiovisi...e,Response to the approvable letter received from ...ion (FDA) for Sanvar(R), or Debio 8609 (vapreotide...
Other Medicine Technology:U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin(R) Adjuvant 2U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin(R) Adjuvant 3U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin(R) Adjuvant 4U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin(R) Adjuvant 5Sanvar(R) (Debio 8609) for Esophageal Variceal Bleeding 2Sanvar(R) (Debio 8609) for Esophageal Variceal Bleeding 3
(Date:11/22/2009)...ld Famous Lasik surgeon, Dr. Gulani continues to i...ursuit for vision beyond 20/20.,Known as the Docto... and is widely published in teaching LASIK surgeon..., FL (PRWEB) November 22, 2009 -- Dr. Arun C. Gula...by Goldline Research as one of the leading Laser E...
(Date:11/22/2009)...Physician-scientists from Weill Cornell Medical Co...ay prove to be a powerful target for the treatment...affects lymphocytes, or white blood cells. By expl...to powerfully suppress tumor formation in lab test...ve led to the design of a clinical trial that will...
(Date:11/22/2009)...lthSmart, an innovative healthcare benefit solutio...ly completed a recapitalization with Silver Point ...s. Silver Point Capital, L.P. is a private invest...ecapitalization allows the Company to continue its... (PRWEB) November 22, 2009...
(Date:11/22/2009)... Congressman Chaka Fatt...United States Senate,s vote tonight to proceed to ..., "Senators Arlen Specter and Bob Casey deserve th...for casting stand-up, critical votes in the Senate...rdable Health Care Reform legislation to full deba...
(Date:11/21/2009)...ovides for an unprecedented expansion of federally...is not for preserving and protecting human life? I...Charmaine Yoest ,, WASHINGTON, Nov. 21 /PRNew...ion President and CEO Dr. Charmaine Yoest responde... following statement: ,, "This was a pro-abort...
Breaking Medicine News(10 mins):Health News:Dr. Arun Gulani Listed in Forbes Magazine as One of The Leading Laser Eye Surgeons of the United States 2Health News:New cancer target for non-Hodgkin's lymphoma 2Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2
...May 5 As early diagnosis of cancer is critical fo... of life for patients, better access to diagnostic...vative molecular technologies have generated a wav...s of cancer. , , (Logo: http://www.newscom.com/...
... Bates County Memorial Hospital (BCMH), a 60-be...d the MedGenix financial and patient management sy...l with patient access, revenue cycle management an...ld, MO. Founded in 1992, CHS, MedGenix financial a...
... Howard Leight today officially introduced Quie...asures and records a worker,s actual in-ear exposu...uction is a major advance towards stopping the pro...e only as good the data they,re based upon. Exist...
...o a new study led by researchers at Columbia Unive...ital, there are several factors that contribute to...ings will be reported in a platform presentation a...ur nation,s young children are under-immunized, an...
...p Increase Hispanic Family Physicians in Californi...iser Permanente announced today a $2 million grant...sity of California, Los Angeles , to expand its In...communities and need to pass United States Medical...
...sts guide treatment of patients with non-small cel...six, Inc. today announces U.S. commercial availabi...c test for patients with advanced stage non-small ...receptor tyrosine kinase inhibitors (EGFR-TKIs), s...
Other Medicine News:Health News:Personalized Medicine Makes Significant Headway Following the Rapid Evolution of U.S. Molecular Diagnostics Market, Finds Frost & Sullivan 2Health News:Personalized Medicine Makes Significant Headway Following the Rapid Evolution of U.S. Molecular Diagnostics Market, Finds Frost & Sullivan 3Health News:Personalized Medicine Makes Significant Headway Following the Rapid Evolution of U.S. Molecular Diagnostics Market, Finds Frost & Sullivan 4Health News:MedGenix Financial Information System Selected by Bates County Memorial Hospital 2Health News:Howard Leight Introduces QuietDose(TM): In-Ear Dosimetry Measures Noise Exposure in Real-Time to Help Prevent Workplace Hearing Loss 2Health News:Howard Leight Introduces QuietDose(TM): In-Ear Dosimetry Measures Noise Exposure in Real-Time to Help Prevent Workplace Hearing Loss 3Health News:Howard Leight Introduces QuietDose(TM): In-Ear Dosimetry Measures Noise Exposure in Real-Time to Help Prevent Workplace Hearing Loss 4Health News:Why parents miss their children's immunization visits 2Health News:Why parents miss their children's immunization visits 3Health News:Kaiser Permanente Grant to Expand UCLA International Medical Center Graduate Program 2Health News:Kaiser Permanente Grant to Expand UCLA International Medical Center Graduate Program 3Health News:Kaiser Permanente Grant to Expand UCLA International Medical Center Graduate Program 4Health News:Biodesix Advances the Field of Personalized Medicine With the Launch of VeriStrat(R) 2Health News:Biodesix Advances the Field of Personalized Medicine With the Launch of VeriStrat(R) 3
Storz Phaco Protige
Storz Phaco Premiere
Compact Ultrasonic Phacoemulsification System
...t workstation is a unique combination of Paradigm'...nfinite flexibility for modular hardware modificat... changing cataract surgical techniques and deliver...atforms providing open architecture to accommodate...
Medicine Products: